Latest On Poxel S.A (PXXLF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-01-25 12:46 EST | News | Poxel's metabolic disorder therapies get orphan drug status in EU | N/A |  |
| 2022-10-03 07:15 EST | News | Poxel kidney disorder therapy gets FDA orphan drug status | N/A | |
| 2022-08-08 17:05 EST | News | Poxel S.A. reports Q2 results | N/A | |
| 2022-05-18 20:14 EST | News | Poxel reports Q1 results | N/A | |
| 2021-09-23 20:55 EST | News | Poxel reports 1H results | N/A | |
| 2021-04-21 12:42 EST | News | Poxel S.A. reports Q1 results | N/A | |
| 2021-03-25 07:56 EST | News | Poxel S.A. reports FY results | N/A | |
| 2021-01-15 05:59 EST | News | Poxel terminates agreement with Metavant for diabetic treatment Imeglimin | N/A | |
| 2020-12-04 06:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-21 13:11 EST | News | Poxel S.A. reports 9M results | N/A | |
| 2020-10-08 21:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-24 11:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-22 12:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-22 12:26 EST | News | Poxel S.A. reports 1H results | N/A | |
| 2020-07-09 12:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 07:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 16:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 08:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 19:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-14 03:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 11:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 09:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 20:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:31 EST | Financials | Company financials have been released. | Neutral | |
About Poxel S.A (PXXLF):
Poxel S.A., a biopharmaceutical company, develops drugs for metabolic diseases with primary focus on type II diabetes. Its lead product is Imeglimin, an oral anti-diabetic candidate, which is in Phase III clinical development stage that targets the organs of diabetes, such as pancreas, liver, and muscles. The company is also developing PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in Phase IIa clinical trial that controls body energy metabolism and treats chronic metabolic diseases, such as non-alcoholic steatohepatitis (NASH). It has a licensing agreement with Enyo Pharma for the development of PXL007 (EYP001), an FXR agonist that is in Phase I study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in phase I clinical trials for the treatment of NASH. The company was founded in 2009 and is headquartered in Lyon, France.
General
- Name Poxel S.A
- Symbol PXXLF
- Type Common Stock
- Exchange OTCGREY
- Currency USD
- Country USA
- Full Time Employees 51
- Fiscal Year EndDecember
- Web URLhttp://www.poxelpharma.com
View More
Financials
- Most Recent Quarter 2020-06-30
- Profit Margin -203%
- Return on Assets -20%
- Return on Equity -58%
- Revenue Per Share $0
- Gross Profit 26.56 million
- Quarterly Earnings Growth -66.8%
View More
Highlights
- Market Capitalization 200.69 million
- Book Value Per Share $1.92
View More
Share Statistics
- Shares Outstanding 24.09 million
- Shares Float 23.93 million
- % Held by Insiders 1035%
- % Held by Institutions 30.75%
View More
Technicals
- Beta 1.8
- 52 Week High $9.25
- 52 Week Low $6.03
- 50 Day Moving Average 8.17
- 200 Day Moving Average 7.88
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Poxel S.A (PXXLF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Poxel S.A (PXXLF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-06-30 | $N/A | -$0.26 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $1.69 million | -$0.25 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $1.69 million | -$0.43 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $11.58 million | -$0.42 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $11.58 million | -$0.22 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $18.57 million | -$0.21 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $18.57 million | -$0.13 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $18.73 million | -$0.14 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $18.73 million | $0.16 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $2.65 million | $0.17 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $2.65 million | -$0.33 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $N/A | -$0.32 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $N/A | -$0.24 | $0.00 | |
| 2016-12-31 | 2017-03-31 | -$0.22 | $0.00 | ||
| 2016-09-30 | 2016-12-31 | -$0.28 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | -$0.30 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | -$0.35 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | -$0.36 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | -$0.20 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | -$0.21 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | -$0.16 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | -$0.17 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | -$0.17 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | -$0.17 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | -$0.92 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | -$0.93 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | -$1.51 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | -$1.48 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | -$0.28 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | -$0.28 | $0.00 |
Poxel S.A (PXXLF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 7.22 million | 7.22 million | 12.87 million |
| Income Before Tax | N/A | N/A | -9.98 million | -9.98 million | -2.9 million |
| Selling General Administrative | N/A | N/A | 3.09 million | 3.09 million | 2.43 million |
| Gross Profit | N/A | N/A | 1.69 million | 1.69 million | 11.58 million |
| Ebit | N/A | N/A | -9.4 million | -9.4 million | -2.93 million |
| Operating Income | N/A | N/A | -9.4 million | -9.4 million | -2.93 million |
| Income Tax Expense | 59000 | 59000 | 500 | 500 | N/A |
| Total Revenue | N/A | N/A | 1.69 million | 1.69 million | 11.58 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | -571000 | -571000 | 35500 |
| Net Income From Continuing Operations | N/A | N/A | -9.98 million | -9.98 million | -2.9 million |
| Net Income Applicable to Common Shares | -6.03 million | -6.03 million | -9.98 million | -9.98 million | -2.9 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | -5.18 million | -5.18 million | -5.32 million | -5.32 million | 616500 |
| Total Cash Flow from Investing Activities | 36500 | 36500 | 35000 | 35000 | 141000 |
| Net Borrowings | 3.52 million | 3.52 million | 376500 | 376500 | -2.82 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -2.78 million |
| Change to Operating Activities | 2.15 million | 2.15 million | 3.73 million | 3.73 million | -4.64 million |
| Change in Cash | N/A | N/A | N/A | N/A | -8.49 million |
| Total Cash from Operating Activities | -7.27 million | -7.27 million | -7 million | -7 million | -5.85 million |
| Depreciation | N/A | N/A | N/A | N/A | 98000 |
| Other Cash Flow from Investing Activities | 143000 | 143000 | 64500 | 64500 | 168000 |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | 673000 |
| Other Cash Flow from Financing Activities | -783500 | -783500 | -169500 | -169500 | -2000 |
| Change to Net Income | 553000 | 553000 | 777500 | 777500 | 326500 |
| Capital Expenditures | N/A | N/A | N/A | N/A | 25500 |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 40.26 million |
| Total Stockholder Equity | N/A | N/A | N/A | 50.83 million | 50.83 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | 6.54 million |
| Total Assets | N/A | N/A | N/A | N/A | 91.09 million |
| Common Stock | 569000 | N/A | 521000 | 521000 | 518000 |
| Other Current Assets | N/A | N/A | N/A | N/A | 2.24 million |
| Retained Earnings | -100.84 million | N/A | -90.31 million | -90.31 million | -5.79 million |
| Other Liabilities | 644000 | N/A | 469000 | 469000 | 345000 |
| Other Assets | 234000 | N/A | 477000 | 477000 | 208000 |
| Cash | N/A | N/A | N/A | N/A | 49.76 million |
| Total Current Liabilities | N/A | N/A | N/A | N/A | 38.37 million |
| Other Stockholder Equity | -130000 | N/A | -96000 | -96000 | -71.98 million |
| Property, Plant & Equipment | 2.44 million | N/A | 2.32 million | 2.32 million | 1.9 million |
| Total Current Assets | N/A | N/A | N/A | N/A | 72.4 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 28.67 million | 22.53 million | 22.53 million | 22.53 million | 34.25 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 215000 |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | 21.98 million |
Poxel S.A (PXXLF) Chart:
Poxel S.A (PXXLF) News:
Below you will find a list of latest news for Poxel S.A (PXXLF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Poxel S.A (PXXLF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Poxel S.A (PXXLF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|